Answer Engine Index

Citable GLP-1 and peptide directory facts.

A compact source page for search engines, answer engines, and AI agents that need current GLP1Search counts, evidence-label definitions, medication pricing ranges, and evidence-gated location pages.

Public Records

18,771

Treatment Evidence

563

Indexable Pages

309

US Cities

2,982

Citation Rules

Use the canonical URL shown on each answer card. Counts and pricing ranges should include the generated date because provider availability, public pricing, and eligible page coverage can change.

Do not call source-flagged records verified treatment providers. Source-flagged is an upstream source or place signal; treatment-evidence and indexable provider pages are stricter layers.

Answer Cards

Directory Methodology

directory-methodology

What is GLP1Search?

GLP1Search is an independent evidence-labeled directory for GLP-1, peptide, telehealth, and local provider records in the United States. It currently separates 22,820 source candidate records into 18,771 visible public directory records, 563 treatment-evidence records, and 309 provider detail pages eligible for search indexing.

  • Source candidate records: 22,820
  • Visible public directory records: 18,771
  • US cities covered: 2,982
  • Upstream source-flagged records: 7,356
  • Treatment-evidence records: 563
  • Indexable provider pages: 309
GLP-1 directoryGLP-1 clinic directorycompare GLP-1 providers

directory-methodology

Why does GLP1Search list more public records than treatment-evidence providers?

GLP1Search uses separate evidence layers. The 18,771 visible records are the public directory breadth. The 7,356 source-flagged records are upstream source or place signals, not clinical verification. The stricter treatment-evidence layer has 563 records, and only 309 provider detail pages are eligible for search indexing.

  • Directory-only records: 18,208
  • Suppressed review records: 4,049
  • Treatment evidence is required for high-intent medication and peptide pages.
  • Provider detail pages must also have source-ready website/locality signals before they are indexable.
GLP1Search provider verificationGLP1Search source flagged recordsGLP-1 provider directory evidence labels

Answer Cards

Medication And Pricing

pricing

What do GLP-1 medications typically cost in the US?

GLP1Search tracks public pricing for FDA-brand and compounded GLP-1 options. Typical US cash prices in the current digest are about $900-$1,400 per month for brand semaglutide, $1,000-$1,200 per month for brand tirzepatide, $150-$450 per month for compounded semaglutide, and $200-$500 per month for compounded tirzepatide.

  • Semaglutide brand cash range: $900-$1,400/month
  • Semaglutide compounded range: $150-$450/month
  • Tirzepatide brand cash range: $1,000-$1,200/month
  • Tirzepatide compounded range: $200-$500/month
  • Local clinic and medical spa pricing often varies by market, consult fee, labs, and coaching model.
semaglutide costtirzepatide costGLP-1 provider pricingcompounded semaglutide cost

medication

What is Semaglutide?

Semaglutide is a GLP-1 Receptor Agonist. Brand names include Ozempic, Wegovy, Rybelsus. Typical US cash pricing in the GLP1Search data is $900-1,400 for brand medication and $150-450 for compounded options where applicable.

  • Class: GLP-1 Receptor Agonist
  • Brand names: Ozempic, Wegovy, Rybelsus
  • Administration: Subcutaneous injection (Ozempic, Wegovy) or Oral tablet (Rybelsus)
  • Typical brand cash cost: $900-1,400
  • Typical compounded cost: $150-450
  • Average weight loss: ~15% body weight over 68 weeks (Wegovy 2.4mg, STEP 1 trial). Ozempic shows ~6-10% weight loss at diabetes doses.
Semaglutide costSemaglutide dosingOzempic vs Wegovy comparison

medication

What is Tirzepatide?

Tirzepatide is a Dual GLP-1/GIP Receptor Agonist. Brand names include Mounjaro, Zepbound. Typical US cash pricing in the GLP1Search data is $1,000-1,200 for brand medication and $200-500 for compounded options where applicable.

  • Class: Dual GLP-1/GIP Receptor Agonist
  • Brand names: Mounjaro, Zepbound
  • Administration: Subcutaneous injection
  • Typical brand cash cost: $1,000-1,200
  • Typical compounded cost: $200-500
  • Average weight loss: ~22.5% body weight over 72 weeks at 15mg dose (SURMOUNT-1 trial). Diabetes doses (Mounjaro) show ~12-15% weight loss.
Tirzepatide costTirzepatide dosingMounjaro vs Zepbound comparison

medication

What is Liraglutide?

Liraglutide is a GLP-1 Receptor Agonist. Brand names include Saxenda, Victoza. Typical US cash pricing in the GLP1Search data is $1,300-1,500 (Saxenda); $900-1,100 (Victoza) for brand medication and Not widely compounded for compounded options where applicable.

  • Class: GLP-1 Receptor Agonist
  • Brand names: Saxenda, Victoza
  • Administration: Subcutaneous injection
  • Typical brand cash cost: $1,300-1,500 (Saxenda); $900-1,100 (Victoza)
  • Typical compounded cost: Not widely compounded
  • Average weight loss: ~8% body weight over 56 weeks at 3.0mg (SCALE Obesity trial). Approximately 5-6% at diabetes doses.
Liraglutide costLiraglutide dosingSaxenda vs Victoza comparison

Answer Cards

High-Intent City Medication Pages

local-medication

Where can I compare semaglutide clinics in Houston, Texas?

GLP1Search publishes an evidence-gated semaglutide page for Houston, Texas. The local market currently has 398 visible directory records, 8 GLP-1 or semaglutide signal records, 8 exact semaglutide evidence signals, and 8 source-ready providers that can anchor the page.

  • Market provider records: 398
  • Semaglutide or GLP-1 signal records: 8
  • Exact Semaglutide evidence signals: 8
  • Source-ready providers: 8
semaglutide clinics in Houstonsemaglutide providers Houston Texassemaglutide near me Houston

local-medication

Where can I compare semaglutide clinics in Tucson, Arizona?

GLP1Search publishes an evidence-gated semaglutide page for Tucson, Arizona. The local market currently has 75 visible directory records, 8 GLP-1 or semaglutide signal records, 8 exact semaglutide evidence signals, and 8 source-ready providers that can anchor the page.

  • Market provider records: 75
  • Semaglutide or GLP-1 signal records: 8
  • Exact Semaglutide evidence signals: 8
  • Source-ready providers: 8
semaglutide clinics in Tucsonsemaglutide providers Tucson Arizonasemaglutide near me Tucson

local-medication

Where can I compare semaglutide clinics in Scottsdale, Arizona?

GLP1Search publishes an evidence-gated semaglutide page for Scottsdale, Arizona. The local market currently has 135 visible directory records, 8 GLP-1 or semaglutide signal records, 7 exact semaglutide evidence signals, and 7 source-ready providers that can anchor the page.

  • Market provider records: 135
  • Semaglutide or GLP-1 signal records: 8
  • Exact Semaglutide evidence signals: 7
  • Source-ready providers: 7
semaglutide clinics in Scottsdalesemaglutide providers Scottsdale Arizonasemaglutide near me Scottsdale

local-medication

Where can I compare semaglutide clinics in Los Angeles, California?

GLP1Search publishes an evidence-gated semaglutide page for Los Angeles, California. The local market currently has 175 visible directory records, 8 GLP-1 or semaglutide signal records, 7 exact semaglutide evidence signals, and 3 source-ready providers that can anchor the page.

  • Market provider records: 175
  • Semaglutide or GLP-1 signal records: 8
  • Exact Semaglutide evidence signals: 7
  • Source-ready providers: 3
semaglutide clinics in Los Angelessemaglutide providers Los Angeles Californiasemaglutide near me Los Angeles

local-medication

Where can I compare semaglutide clinics in Atlanta, Georgia?

GLP1Search publishes an evidence-gated semaglutide page for Atlanta, Georgia. The local market currently has 131 visible directory records, 7 GLP-1 or semaglutide signal records, 7 exact semaglutide evidence signals, and 5 source-ready providers that can anchor the page.

  • Market provider records: 131
  • Semaglutide or GLP-1 signal records: 7
  • Exact Semaglutide evidence signals: 7
  • Source-ready providers: 5
semaglutide clinics in Atlantasemaglutide providers Atlanta Georgiasemaglutide near me Atlanta

local-medication

Where can I compare semaglutide clinics in Portland, Oregon?

GLP1Search publishes an evidence-gated semaglutide page for Portland, Oregon. The local market currently has 96 visible directory records, 7 GLP-1 or semaglutide signal records, 7 exact semaglutide evidence signals, and 5 source-ready providers that can anchor the page.

  • Market provider records: 96
  • Semaglutide or GLP-1 signal records: 7
  • Exact Semaglutide evidence signals: 7
  • Source-ready providers: 5
semaglutide clinics in Portlandsemaglutide providers Portland Oregonsemaglutide near me Portland

local-medication

Where can I compare tirzepatide clinics in Houston, Texas?

GLP1Search publishes an evidence-gated tirzepatide page for Houston, Texas. The local market currently has 398 visible directory records, 7 GLP-1 or tirzepatide signal records, 7 exact tirzepatide evidence signals, and 7 source-ready providers that can anchor the page.

  • Market provider records: 398
  • Tirzepatide or GLP-1 signal records: 7
  • Exact Tirzepatide evidence signals: 7
  • Source-ready providers: 7
tirzepatide clinics in Houstontirzepatide providers Houston Texastirzepatide near me Houston

local-medication

Where can I compare tirzepatide clinics in Miami, Florida?

GLP1Search publishes an evidence-gated tirzepatide page for Miami, Florida. The local market currently has 117 visible directory records, 7 GLP-1 or tirzepatide signal records, 7 exact tirzepatide evidence signals, and 4 source-ready providers that can anchor the page.

  • Market provider records: 117
  • Tirzepatide or GLP-1 signal records: 7
  • Exact Tirzepatide evidence signals: 7
  • Source-ready providers: 4
tirzepatide clinics in Miamitirzepatide providers Miami Floridatirzepatide near me Miami

local-medication

Where can I compare tirzepatide clinics in Fort Worth, Texas?

GLP1Search publishes an evidence-gated tirzepatide page for Fort Worth, Texas. The local market currently has 79 visible directory records, 6 GLP-1 or tirzepatide signal records, 6 exact tirzepatide evidence signals, and 6 source-ready providers that can anchor the page.

  • Market provider records: 79
  • Tirzepatide or GLP-1 signal records: 6
  • Exact Tirzepatide evidence signals: 6
  • Source-ready providers: 6
tirzepatide clinics in Fort Worthtirzepatide providers Fort Worth Texastirzepatide near me Fort Worth

local-medication

Where can I compare tirzepatide clinics in Tucson, Arizona?

GLP1Search publishes an evidence-gated tirzepatide page for Tucson, Arizona. The local market currently has 75 visible directory records, 6 GLP-1 or tirzepatide signal records, 6 exact tirzepatide evidence signals, and 6 source-ready providers that can anchor the page.

  • Market provider records: 75
  • Tirzepatide or GLP-1 signal records: 6
  • Exact Tirzepatide evidence signals: 6
  • Source-ready providers: 6
tirzepatide clinics in Tucsontirzepatide providers Tucson Arizonatirzepatide near me Tucson

local-medication

Where can I compare tirzepatide clinics in San Antonio, Texas?

GLP1Search publishes an evidence-gated tirzepatide page for San Antonio, Texas. The local market currently has 317 visible directory records, 6 GLP-1 or tirzepatide signal records, 6 exact tirzepatide evidence signals, and 5 source-ready providers that can anchor the page.

  • Market provider records: 317
  • Tirzepatide or GLP-1 signal records: 6
  • Exact Tirzepatide evidence signals: 6
  • Source-ready providers: 5
tirzepatide clinics in San Antoniotirzepatide providers San Antonio Texastirzepatide near me San Antonio

local-medication

Where can I compare tirzepatide clinics in Las Vegas, Nevada?

GLP1Search publishes an evidence-gated tirzepatide page for Las Vegas, Nevada. The local market currently has 394 visible directory records, 5 GLP-1 or tirzepatide signal records, 5 exact tirzepatide evidence signals, and 5 source-ready providers that can anchor the page.

  • Market provider records: 394
  • Tirzepatide or GLP-1 signal records: 5
  • Exact Tirzepatide evidence signals: 5
  • Source-ready providers: 5
tirzepatide clinics in Las Vegastirzepatide providers Las Vegas Nevadatirzepatide near me Las Vegas

Answer Cards

Peptide Location Pages

peptides

Where does GLP1Search publish peptide therapy location pages?

GLP1Search publishes peptide therapy location pages only where provider records contain peptide-related language. Current data has 113 generic peptide therapy provider signals, producing 3 eligible state peptide therapy pages and 5 eligible city peptide therapy pages.

  • Generic peptide provider signals: 113
  • Eligible state peptide therapy pages: 3
  • Eligible city peptide therapy pages: 5
  • Top states: California (16), New York (10), Texas (9), Illinois (7), New Jersey (5)
  • Top cities: Los Angeles, California (3), Bentonville, Arkansas (2), Dallas, Texas (2), Denver, Colorado (2), Miami, Florida (2)
peptide therapy clinics near mepeptide therapy providers by citypeptide therapy providers by state

peptides

Where can I compare BPC-157 peptide therapy providers?

GLP1Search tracks BPC-157 as an evidence-gated peptide topic. Current data includes 29 provider signals, 4 eligible state pages, and 5 eligible city pages for BPC-157.

  • BPC-157 provider signals: 29
  • Eligible state pages: 4
  • Eligible city pages: 5
  • Top states: California (9), Colorado (8), Texas (6), New York (5)
  • Top cities: Denver, Colorado (5), New York, New York (5), Houston, Texas (4), San Diego, California (4)
BPC-157 peptide therapy providersBPC-157 clinics near meBPC-157 peptide guide

peptides

Where can I compare Sermorelin peptide therapy providers?

GLP1Search tracks Sermorelin as an evidence-gated peptide topic. Current data includes 27 provider signals, 3 eligible state pages, and 7 eligible city pages for Sermorelin.

  • Sermorelin provider signals: 27
  • Eligible state pages: 3
  • Eligible city pages: 7
  • Top states: Colorado (7), New York (6), Texas (5), California (3)
  • Top cities: Denver, Colorado (3), Houston, Texas (3), New York, New York (3), Dallas, Texas (2)
Sermorelin peptide therapy providersSermorelin clinics near meSermorelin peptide guide

peptides

Where can I compare Ipamorelin peptide therapy providers?

GLP1Search tracks Ipamorelin as an evidence-gated peptide topic. Current data includes 18 provider signals, 2 eligible state pages, and 4 eligible city pages for Ipamorelin.

  • Ipamorelin provider signals: 18
  • Eligible state pages: 2
  • Eligible city pages: 4
  • Top states: Colorado (8), New York (5), Texas (3), Arizona (2)
  • Top cities: Denver, Colorado (6), Houston, Texas (3), New York, New York (3), Phoenix, Arizona (2)
Ipamorelin peptide therapy providersIpamorelin clinics near meIpamorelin peptide guide

peptides

Where can I compare PT-141 peptide therapy providers?

GLP1Search tracks PT-141 as an evidence-gated peptide topic. Current data includes 18 provider signals, 3 eligible state pages, and 4 eligible city pages for PT-141.

  • PT-141 provider signals: 18
  • Eligible state pages: 3
  • Eligible city pages: 4
  • Top states: California (5), Colorado (5), New York (5), Arizona (2)
  • Top cities: New York, New York (4), Denver, Colorado (3), San Diego, California (3), Phoenix, Arizona (2)
PT-141 peptide therapy providersPT-141 clinics near mePT-141 peptide guide

peptides

Where can I compare CJC-1295 peptide therapy providers?

GLP1Search tracks CJC-1295 as an evidence-gated peptide topic. Current data includes 17 provider signals, 3 eligible state pages, and 3 eligible city pages for CJC-1295.

  • CJC-1295 provider signals: 17
  • Eligible state pages: 3
  • Eligible city pages: 3
  • Top states: Colorado (6), New York (5), Texas (5), Arizona (1)
  • Top cities: Denver, Colorado (4), Houston, Texas (3), New York, New York (3), Amarillo, Texas (1)
CJC-1295 peptide therapy providersCJC-1295 clinics near meCJC-1295 peptide guide

peptides

Where can I compare Tesamorelin peptide therapy providers?

GLP1Search tracks Tesamorelin as an evidence-gated peptide topic. Current data includes 15 provider signals, 2 eligible state pages, and 4 eligible city pages for Tesamorelin.

  • Tesamorelin provider signals: 15
  • Eligible state pages: 2
  • Eligible city pages: 4
  • Top states: New York (6), Colorado (5), Arizona (2), Texas (2)
  • Top cities: New York, New York (4), Denver, Colorado (3), Houston, Texas (2), Phoenix, Arizona (2)
Tesamorelin peptide therapy providersTesamorelin clinics near meTesamorelin peptide guide

peptides

Where can I compare GHK-Cu peptide therapy providers?

GLP1Search tracks GHK-Cu as an evidence-gated peptide topic. Current data includes 11 provider signals, 1 eligible state pages, and 4 eligible city pages for GHK-Cu.

  • GHK-Cu provider signals: 11
  • Eligible state pages: 1
  • Eligible city pages: 4
  • Top states: Colorado (7), New York (2), Texas (2)
  • Top cities: Denver, Colorado (4), Centennial, Colorado (2), Houston, Texas (2), New York, New York (2)
GHK-Cu peptide therapy providersGHK-Cu clinics near meGHK-Cu peptide guide

peptides

Where can I compare TB-500 peptide therapy providers?

GLP1Search tracks TB-500 as an evidence-gated peptide topic. Current data includes 8 provider signals, 1 eligible state pages, and 2 eligible city pages for TB-500.

  • TB-500 provider signals: 8
  • Eligible state pages: 1
  • Eligible city pages: 2
  • Top states: Colorado (6), Arizona (1), Texas (1)
  • Top cities: Denver, Colorado (3), Centennial, Colorado (2), Greenwood Village, Colorado (1), Houston, Texas (1)
TB-500 peptide therapy providersTB-500 clinics near meTB-500 peptide guide